The U.S. Food and Drug Administration (FDA) has released new target dates for several significant rulemaking activities related to Modernization of Cosmetics Regulation Act (MoCRA) and other federal updates. The recently published Spring 2026 Health and Human Services (HHS) Unified Agenda reveals shifts in timelines for fragrance allergen labeling, Good Manufacturing Practices (GMP) and other key areas that will impact the cosmetics industry.

Here are the key takeaways from the latest update:

  • Disclosure of Fragrance Allergens in Cosmetic Labeling: The anticipated date for this proposed rule has been moved to May 2026. This is a significant delay from its previous target of January 2025.
  • GMP proposed Rule: The proposed rule for cosmetic Good Manufacturing Practices has been moved from the standard agenda to the “long-term actions list.” This indicates that the Agency is unlikely to publish the Notice of Proposed Rulemaking (NPRM) within the next 12 months. The previous anticipated date was October 2025.
  • Formaldehyde in Hair Straightening Products: While not a direct provision of MoCRA, the FDA’s intention to ban formaldehyde and formaldehyde-releasers in these products has a new anticipated NPRM date of December 2025. This timeline has been previously pushed back from September 2024 and March 2025.
  • Test Methods for Asbestos in Talc: The Final Rule for standardized testing methods for detecting asbestos in talc-containing cosmetic products is now targeted for March 2026.

These adjustments reflect the ongoing complexities of implementing major regulatory changes. Our team at Focal Point Research will continue to monitor these developments and provide updates as they become available.